Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Erratum for Hoft et al., "The Rate of CD4 T Cell Entry into the Lungs during Mycobacterium tuberculosis Infection Is Determined by Partial and Opposing Effects of Multiple Chemokine Receptors".

Hoft SG, Sallin MA, Kauffman KD, Sakai S, Ganusov VV, Barber DL.

Infect Immun. 2019 Aug 21;87(9). pii: e00491-19. doi: 10.1128/IAI.00491-19. Print 2019 Sep. No abstract available.

2.

Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from Cryptococcus gattii Independently of T Cells.

Davis MJ, Moyer S, Hoke ES, Sionov E, Mayer-Barber KD, Barber DL, Cai H, Jenkins L, Walter PJ, Chang YC, Kwon-Chung KJ.

MBio. 2019 Jun 18;10(3). pii: e00799-19. doi: 10.1128/mBio.00799-19.

3.

Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques.

Namasivayam S, Kauffman KD, McCulloch JA, Yuan W, Thovarai V, Mittereder LR, Trinchieri G, Barber DL, Sher A.

MBio. 2019 Jun 4;10(3). pii: e01018-19. doi: 10.1128/mBio.01018-19.

4.

Drosophila anion exchanger 2 is required for proper ovary development and oogenesis.

Benitez M, Tatapudy S, Liu Y, Barber DL, Nystul TG.

Dev Biol. 2019 Aug 15;452(2):127-133. doi: 10.1016/j.ydbio.2019.04.018. Epub 2019 May 7.

PMID:
31071312
5.

Tau repeat regions contain conserved histidine residues that modulate microtubule-binding in response to changes in pH.

Charafeddine RA, Cortopassi WA, Lak P, Tan R, McKenney RJ, Jacobson MP, Barber DL, Wittmann T.

J Biol Chem. 2019 May 31;294(22):8779-8790. doi: 10.1074/jbc.RA118.007004. Epub 2019 Apr 16.

PMID:
30992364
6.

Intracellular pH dynamics and charge-changing somatic mutations in cancer.

White KA, Kisor K, Barber DL.

Cancer Metastasis Rev. 2019 Jun;38(1-2):17-24. doi: 10.1007/s10555-019-09791-8. Review.

PMID:
30982102
7.

The Rate of CD4 T Cell Entry into the Lungs during Mycobacterium tuberculosis Infection Is Determined by Partial and Opposing Effects of Multiple Chemokine Receptors.

Hoft SG, Sallin MA, Kauffman KD, Sakai S, Ganusov VV, Barber DL.

Infect Immun. 2019 May 21;87(6). pii: e00841-18. doi: 10.1128/IAI.00841-18. Print 2019 Jun. Erratum in: Infect Immun. 2019 Aug 21;87(9):.

PMID:
30962399
8.

Tuberculosis following PD-1 blockade for cancer immunotherapy.

Barber DL, Sakai S, Kudchadkar RR, Fling SP, Day TA, Vergara JA, Ashkin D, Cheng JH, Lundgren LM, Raabe VN, Kraft CS, Nieva JJ, Cheever MA, Nghiem PT, Sharon E.

Sci Transl Med. 2019 Jan 16;11(475). pii: eaat2702. doi: 10.1126/scitranslmed.aat2702.

PMID:
30651320
9.

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):947-951. doi: 10.1164/rccm.201807-1273PP. No abstract available.

PMID:
30428263
10.

β-Catenin is a pH sensor with decreased stability at higher intracellular pH.

White KA, Grillo-Hill BK, Esquivel M, Peralta J, Bui VN, Chire I, Barber DL.

J Cell Biol. 2018 Nov 5;217(11):3965-3976. doi: 10.1083/jcb.201712041. Epub 2018 Oct 12.

11.

Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression.

Sallin MA, Kauffman KD, Riou C, Du Bruyn E, Foreman TW, Sakai S, Hoft SG, Myers TG, Gardina PJ, Sher A, Moore R, Wilder-Kofie T, Moore IN, Sette A, Lindestam Arlehamn CS, Wilkinson RJ, Barber DL.

Nat Microbiol. 2018 Nov;3(11):1198-1205. doi: 10.1038/s41564-018-0231-6. Epub 2018 Sep 10.

12.

Limited Pulmonary Mucosal-Associated Invariant T Cell Accumulation and Activation during Mycobacterium tuberculosis Infection in Rhesus Macaques.

Kauffman KD, Sallin MA, Hoft SG, Sakai S, Moore R, Wilder-Kofie T, Moore IN, Sette A, Arlehamn CSL, Barber DL.

Infect Immun. 2018 Nov 20;86(12). pii: e00431-18. doi: 10.1128/IAI.00431-18. Print 2018 Dec.

13.

Formin-dependent TGF-β signaling for epithelial to mesenchymal transition.

Rana MK, Aloisio FM, Choi C, Barber DL.

Mol Biol Cell. 2018 Jun 15;29(12):1465-1475. doi: 10.1091/mbc.E17-05-0325. Epub 2018 Apr 18.

14.

A Histidine pH sensor regulates activation of the Ras-specific guanine nucleotide exchange factor RasGRP1.

Vercoulen Y, Kondo Y, Iwig JS, Janssen AB, White KA, Amini M, Barber DL, Kuriyan J, Roose JP.

Elife. 2017 Sep 27;6. pii: e29002. doi: 10.7554/eLife.29002.

15.

Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.

White KA, Ruiz DG, Szpiech ZA, Strauli NB, Hernandez RD, Jacobson MP, Barber DL.

Sci Signal. 2017 Sep 5;10(495). pii: eaam9931. doi: 10.1126/scisignal.aam9931.

16.

Prominent features of the amino acid mutation landscape in cancer.

Szpiech ZA, Strauli NB, White KA, Ruiz DG, Jacobson MP, Barber DL, Hernandez RD.

PLoS One. 2017 Aug 24;12(8):e0183273. doi: 10.1371/journal.pone.0183273. eCollection 2017.

17.

Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques.

Kauffman KD, Sallin MA, Sakai S, Kamenyeva O, Kabat J, Weiner D, Sutphin M, Schimel D, Via L, Barry CE 3rd, Wilder-Kofie T, Moore I, Moore R, Barber DL.

Mucosal Immunol. 2018 Mar;11(2):462-473. doi: 10.1038/mi.2017.60. Epub 2017 Jul 26.

18.

PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients.

Zhang Y, Ma CA, Lawrence MG, Break TJ, O'Connell MP, Lyons JJ, López DB, Barber JS, Zhao Y, Barber DL, Freeman AF, Holland SM, Lionakis MS, Milner JD.

J Exp Med. 2017 Sep 4;214(9):2523-2533. doi: 10.1084/jem.20161427. Epub 2017 Jul 14.

19.

The glycolytic enzyme phosphofructokinase-1 assembles into filaments.

Webb BA, Dosey AM, Wittmann T, Kollman JM, Barber DL.

J Cell Biol. 2017 Aug 7;216(8):2305-2313. doi: 10.1083/jcb.201701084. Epub 2017 Jun 23.

20.

The Helper T Cell's Dilemma in Tuberculosis.

Barber DL.

Cell Host Microbe. 2017 Jun 14;21(6):655-656. doi: 10.1016/j.chom.2017.06.004.

21.

Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34+ Cells for Correction of Fabry Disease.

Huang J, Khan A, Au BC, Barber DL, López-Vásquez L, Prokopishyn NL, Boutin M, Rothe M, Rip JW, Abaoui M, Nagree MS, Dworski S, Schambach A, Keating A, West ML, Klassen J, Turner PV, Sirrs S, Rupar CA, Auray-Blais C, Foley R, Medin JA.

Mol Ther Methods Clin Dev. 2017 May 12;5:241-258. doi: 10.1016/j.omtm.2017.05.003. eCollection 2017 Jun 16.

22.

Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis.

Sallin MA, Sakai S, Kauffman KD, Young HA, Zhu J, Barber DL.

Cell Rep. 2017 Mar 28;18(13):3091-3104. doi: 10.1016/j.celrep.2017.03.007.

23.

Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.

Karauzum H, Haudenschild CC, Moore IN, Mahmoudieh M, Barber DL, Datta SK.

J Infect Dis. 2017 Apr 15;215(8):1231-1239. doi: 10.1093/infdis/jix096.

24.

Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.

Kamphorst AO, Wieland A, Nasti T, Yang S, Zhang R, Barber DL, Konieczny BT, Daugherty CZ, Koenig L, Yu K, Sica GL, Sharpe AH, Freeman GJ, Blazar BR, Turka LA, Owonikoko TK, Pillai RN, Ramalingam SS, Araki K, Ahmed R.

Science. 2017 Mar 31;355(6332):1423-1427. doi: 10.1126/science.aaf0683. Epub 2017 Mar 9.

25.

Cancer cell behaviors mediated by dysregulated pH dynamics at a glance.

White KA, Grillo-Hill BK, Barber DL.

J Cell Sci. 2017 Feb 15;130(4):663-669. doi: 10.1242/jcs.195297. Review.

26.

Vaccination for Mycobacterium tuberculosis infection: reprogramming CD4 T-cell homing into the lung.

Barber DL.

Mucosal Immunol. 2017 Mar;10(2):318-321. doi: 10.1038/mi.2016.110. Epub 2016 Dec 14.

PMID:
27966550
27.

Preclinical validation: LV/IL-12 transduction of patient leukemia cells for immunotherapy of AML.

Huang J, Liu Y, Au BC, Barber DL, Arruda A, Schambach A, Rothe M, Minden MD, Paige CJ, Medin JA.

Mol Ther Methods Clin Dev. 2016 Dec 7;3:16074. eCollection 2016.

28.

Increased intracellular pH is necessary for adult epithelial and embryonic stem cell differentiation.

Ulmschneider B, Grillo-Hill BK, Benitez M, Azimova DR, Barber DL, Nystul TG.

J Cell Biol. 2016 Nov 7;215(3):345-355.

29.

A Histidine Cluster in the Cytoplasmic Domain of the Na-H Exchanger NHE1 Confers pH-sensitive Phospholipid Binding and Regulates Transporter Activity.

Webb BA, White KA, Grillo-Hill BK, Schönichen A, Choi C, Barber DL.

J Biol Chem. 2016 Nov 11;291(46):24096-24104. Epub 2016 Sep 20.

30.

CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease.

Sakai S, Kauffman KD, Sallin MA, Sharpe AH, Young HA, Ganusov VV, Barber DL.

PLoS Pathog. 2016 May 31;12(5):e1005667. doi: 10.1371/journal.ppat.1005667. eCollection 2016 May.

31.

Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies.

Xie YL, Rosen LB, Sereti I, Barber DL, Chen RY, Hsu DC, Qasba SS, Zerbe CS, Holland SM, Browne SK.

Clin Infect Dis. 2016 Mar 15;62(6):770-773. doi: 10.1093/cid/civ995. Epub 2015 Dec 8.

32.

Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism.

Rotin LE, Gronda M, MacLean N, Hurren R, Wang X, Lin FH, Wrana J, Datti A, Barber DL, Minden MD, Slassi M, Schimmer AD.

Oncotarget. 2016 Jan 19;7(3):2765-79. doi: 10.18632/oncotarget.6409.

33.

Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis.

Andrade BB, Pavan Kumar N, Amaral EP, Riteau N, Mayer-Barber KD, Tosh KW, Maier N, Conceição EL, Kubler A, Sridhar R, Banurekha VV, Jawahar MS, Barbosa T, Manganiello VC, Moss J, Fontana JR, Marciano BE, Sampaio EP, Olivier KN, Holland SM, Jackson SH, Moayeri M, Leppla S, Sereti I, Barber DL, Nutman TB, Babu S, Sher A.

J Immunol. 2015 Sep 15;195(6):2763-73. doi: 10.4049/jimmunol.1500942. Epub 2015 Aug 12.

34.

Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.

Sionov E, Mayer-Barber KD, Chang YC, Kauffman KD, Eckhaus MA, Salazar AM, Barber DL, Kwon-Chung KJ.

PLoS Pathog. 2015 Aug 7;11(8):e1005040. doi: 10.1371/journal.ppat.1005040. eCollection 2015 Aug.

35.

Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Mayer-Barber KD, Barber DL.

Cold Spring Harb Perspect Med. 2015 Jul 17;5(12). pii: a018424. doi: 10.1101/cshperspect.a018424. Review.

36.

Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production.

Costa PA, Leoratti FM, Figueiredo MM, Tada MS, Pereira DB, Junqueira C, Soares IS, Barber DL, Gazzinelli RT, Antonelli LR.

J Infect Dis. 2015 Dec 15;212(12):1999-2010. doi: 10.1093/infdis/jiv306. Epub 2015 May 27.

37.

Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations.

Webb BA, Forouhar F, Szu FE, Seetharaman J, Tong L, Barber DL.

Nature. 2015 Jul 2;523(7558):111-4. doi: 10.1038/nature14405. Epub 2015 May 18.

38.

Increased H⁺ efflux is sufficient to induce dysplasia and necessary for viability with oncogene expression.

Grillo-Hill BK, Choi C, Jimenez-Vidal M, Barber DL.

Elife. 2015 Mar 20;4. doi: 10.7554/eLife.03270.

39.

Hypoxia increases the abundance but not the assembly of extracellular fibronectin during epithelial cell transdifferentiation.

Rana MK, Srivastava J, Yang M, Chen CS, Barber DL.

J Cell Sci. 2015 Mar 15;128(6):1083-9. doi: 10.1242/jcs.155036. Epub 2015 Jan 22.

40.

The Nck-interacting kinase NIK increases Arp2/3 complex activity by phosphorylating the Arp2 subunit.

LeClaire LL, Rana M, Baumgartner M, Barber DL.

J Cell Biol. 2015 Jan 19;208(2):161-70. doi: 10.1083/jcb.201404095.

41.

Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection.

Penaloza-MacMaster P, Barber DL, Wherry EJ, Provine NM, Teigler JE, Parenteau L, Blackmore S, Borducchi EN, Larocca RA, Yates KB, Shen H, Haining WN, Sommerstein R, Pinschewer DD, Ahmed R, Barouch DH.

Science. 2015 Jan 16;347(6219):278-82. doi: 10.1126/science.aaa2148.

42.

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity.

Broz ML, Binnewies M, Boldajipour B, Nelson AE, Pollack JL, Erle DJ, Barczak A, Rosenblum MD, Daud A, Barber DL, Amigorena S, Van't Veer LJ, Sperling AI, Wolf DM, Krummel MF.

Cancer Cell. 2014 Dec 8;26(6):938. doi: 10.1016/j.ccell.2014.11.010. Epub 2014 Dec 8. No abstract available.

43.

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Broz ML, Binnewies M, Boldajipour B, Nelson AE, Pollack JL, Erle DJ, Barczak A, Rosenblum MD, Daud A, Barber DL, Amigorena S, Van't Veer LJ, Sperling AI, Wolf DM, Krummel MF.

Cancer Cell. 2014 Nov 10;26(5):638-52. doi: 10.1016/j.ccell.2014.09.007. Epub 2014 Oct 16.

44.

Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Behar SM, Carpenter SM, Booty MG, Barber DL, Jayaraman P.

Semin Immunol. 2014 Dec;26(6):559-77. doi: 10.1016/j.smim.2014.09.003. Epub 2014 Oct 11. Review.

45.

Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome.

Andrade BB, Singh A, Narendran G, Schechter ME, Nayak K, Subramanian S, Anbalagan S, Jensen SM, Porter BO, Antonelli LR, Wilkinson KA, Wilkinson RJ, Meintjes G, van der Plas H, Follmann D, Barber DL, Swaminathan S, Sher A, Sereti I.

PLoS Pathog. 2014 Oct 2;10(10):e1004433. doi: 10.1371/journal.ppat.1004433. eCollection 2014 Oct.

46.

Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis.

Sakai S, Mayer-Barber KD, Barber DL.

Curr Opin Immunol. 2014 Aug;29:137-42. doi: 10.1016/j.coi.2014.06.003. Review.

47.

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.

Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, Derrick SC, Shi R, Kumar NP, Wei W, Yuan X, Zhang G, Cai Y, Babu S, Catalfamo M, Salazar AM, Via LE, Barry CE 3rd, Sher A.

Nature. 2014 Jul 3;511(7507):99-103. doi: 10.1038/nature13489. Epub 2014 Jun 25.

48.

Ratiometric imaging of pH probes.

Grillo-Hill BK, Webb BA, Barber DL.

Methods Cell Biol. 2014;123:429-48. doi: 10.1016/B978-0-12-420138-5.00023-9.

PMID:
24974041
49.

Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells.

Sakai S, Kauffman KD, Schenkel JM, McBerry CC, Mayer-Barber KD, Masopust D, Barber DL.

J Immunol. 2014 Apr 1;192(7):2965-9. doi: 10.4049/jimmunol.1400019. Epub 2014 Mar 3.

50.

Intravascular staining for discrimination of vascular and tissue leukocytes.

Anderson KG, Mayer-Barber K, Sung H, Beura L, James BR, Taylor JJ, Qunaj L, Griffith TS, Vezys V, Barber DL, Masopust D.

Nat Protoc. 2014 Jan;9(1):209-22. doi: 10.1038/nprot.2014.005. Epub 2014 Jan 2.

Supplemental Content

Loading ...
Support Center